CASI Pharmaceuticals (CASI) Makes An Impressive Move After The Earnings

As far as premarket action is concerned, it is often an indicator of how the rest of the trading day is going to pan out and one of the stocks that might be tracked by investors at this point is CASI Pharmaceuticals Inc (NASDAQ: CASI).

CASI Pharmaceuticals (CASI) Makes An Impressive Move After The Earnings

The company, which is involved in manufacturing and marketing innovative products, announced its financial results for the full year 2020 on Tuesday. Additionally, it also provided an update on some highlights for this year.

Related:  Asensus Surgical (ASXC) Stock Slumps 75% From the Weak: What's The Buzz?

The market seems to be quite excited about the company’s performance and this morning the CASI stock has jumped 11% in premarket trading. In 2020, the company managed to generate revenues of as much as $15 million which was considerably higher than the $4.1 million worth of revenues that it brought in last year. The cost of generating said revenues soared to $9.5 million in 2020 as opposed to $3.9 million in 2019.

Richard McEntire

Finance and Entertainment Reporter Richard is a bottle of wine - the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.